RECRUITING

Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the Genesis Electrical Impedance Tomography (EIT) imaging system for use in pediatric respiratory disease populations including neuromuscular and bronchopulmonary dysplasia, as well as in age and height matched controls. The EIT does not use radiation, and is read through electrodes.

Official Title

The Associations Between EIT and Clinical Measures During Standard of Care Procedures in Patients With Respiratory Disease: A Preliminary Study

Quick Facts

Study Start:2019-05-03
Study Completion:2024-11-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03797183

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:14 Days to 40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * 2 weeks old - 40 years old
  2. * Premature infants with current age \>2 weeks with a confirmed diagnosis of BPD based on NIH criteria
  3. * Or Chronic respiratory disease due to underlying neuromuscular disease
  4. * Or confirmed neuromuscular disease with an echo completed within the preceding 12 months of study participation of DMD or other diagnoses associated with mild cardiomyopathy.
  5. * have had a VQ scan
  6. * will be undergoing cardiac catherization for for pulmonary vein stenosis, pulmonary hypertension and/or pulmonary artery stenosis
  7. * Or healthy controls
  1. * \<2 weeks of age
  2. * Congenital diaphragmatic hernia
  3. * Severe congenital heart disease
  4. * Significant genetic abnoralities
  5. * Anything that interferes with lead placement on the chest wall
  6. * Unwilling/refusal to sign consent
  7. * Pregnant or lactating
  8. * Pacemaker of other surgical implant and spinal implant (causes noise in the data)
  9. * Moderate to severe cardiomyopathy
  10. * Patients with temporary cognitive disability due to illness

Contacts and Locations

Study Contact

Emily DeBoer, MD
CONTACT
720-777-4953
emily.deboer@childrenscolorado.org

Study Locations (Sites)

Children's Hospital Colorado
Aurora, Colorado, 80045
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-05-03
Study Completion Date2024-11-30

Study Record Updates

Study Start Date2019-05-03
Study Completion Date2024-11-30

Terms related to this study

Additional Relevant MeSH Terms

  • Premature Infant
  • Chronic Respiratory Disease
  • Neuromuscular Diseases
  • Healthy
  • Bronchopulmonary Dysplasia
  • Pulmonary Vein Stenoses